Concentrations of rapamycin required to reduce in vitro cell viability in breast cancer cells and malignant glioma cells, were significantly higher than the concentrations needed to suppress levels of phospho-P70S6K and phospho-4E-BP1 [55–58]. The gene discussed is RPS6KB1; the disease is malignant glioma.